universal blocking and antibody buffer p0268 (Beyotime)
Beyotime is a verified supplier 
Beyotime manufactures this product 
90
Structured Review
Beyotime
universal blocking and antibody buffer p0268
Universal Blocking And Antibody Buffer P0268, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/universal+blocking+buffer/universal+blocking+and+antibody+buffer+p0268/pm40466612-96-15-16
Average 90 stars, based on 1 article reviews
Universal Blocking And Antibody Buffer P0268, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/universal+blocking+buffer/universal+blocking+and+antibody+buffer+p0268/pm40466612-96-15-16
Average 90 stars, based on 1 article reviews
universal blocking and antibody buffer p0268 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Blocking Assay:Article Title: Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathway. Article Snippet: .. All primary antibodies (1:1000) and secondary antibodies(1:10000) were diluted with Article Title: SUMOylation of RAD51 upregulates GOLPH3 expression and promotes cisplatin resistance in colon cancer cells by Sp1 transcriptional activity. Article Snippet: Platinum-based chemotherapy is a first-line treatment for colon cancer.. Previous studies have shown that Golgi phosphoprotein 3 (GOLPH3) overexpression drives platinum resistance in colon cancer and is associated with DNA damage repair (DDR).. However, the mechanism by which DDR induces GOLPH3 expression remains unclear. Incubation:Article Title: SUMOylation of RAD51 upregulates GOLPH3 expression and promotes cisplatin resistance in colon cancer cells by Sp1 transcriptional activity. Article Snippet: Platinum-based chemotherapy is a first-line treatment for colon cancer.. Previous studies have shown that Golgi phosphoprotein 3 (GOLPH3) overexpression drives platinum resistance in colon cancer and is associated with DNA damage repair (DDR).. However, the mechanism by which DDR induces GOLPH3 expression remains unclear. |